470 filings
ARS
2023 FY
ADMA
Adma Biologics Inc
15 Apr 24
Annual report to shareholders
4:40pm
DEFA14A
ADMA
Adma Biologics Inc
15 Apr 24
Additional proxy soliciting materials
4:35pm
DEF 14A
ADMA
Adma Biologics Inc
Definitive proxy
15 Apr 24
4:31pm
8-K
ADMA
Adma Biologics Inc
2 Apr 24
Departure of Directors or Certain Officers
5:16pm
8-K
ADMA
Adma Biologics Inc
11 Mar 24
FDA Approval Provides for Room Temperature (25°C) Storage Conditions for up to 4 Weeks at Any Point During the 36-Month Approved Shelf Life
4:05pm
8-K
usx5ugbdiz6sv60slb38
5 Mar 24
Regulation FD Disclosure
4:05pm
8-K
9oe5 gw01vf3
28 Feb 24
ADMA Biologics Announces CFO Transition
4:21pm
8-K
6f4gyzkemht zjvf
28 Feb 24
ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4:15pm
8-K
nn7p4uqzp iro5j84
21 Feb 24
Other Events
8:00am
8-K
ooo0zy8yhkcvqgaq
8 Jan 24
Regulation FD Disclosure
8:00am
8-K
i7cqm
8 Jan 24
ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business Update
7:30am
8-K
tvspw
18 Dec 23
ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares Management
4:30pm
8-K
khv41i6onee cuj
12 Dec 23
ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient
4:30pm
8-K
72xu3nd
16 Nov 23
ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD
4:31pm
8-K
jsjndm4szmsvrrk
8 Nov 23
ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business Update
4:36pm
8-K
tzzf1n
2 Oct 23
Departure of Directors or Certain Officers
4:45pm
8-K
w6flqc km0
9 Aug 23
ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update
4:15pm